01—Abstract
Summary
Summary of the 8-K filed November 2, 2023. Cited figures are marked; the original filing is the authoritative source.
Moderna, Inc. (MRNA) filed an 8-K on November 2, 2023, primarily to report its financial results for the third quarter ended September 30, 2023.
The company announced its Q3 2023 financial performance via a press release, which is furnished as an exhibit to this filing. Investors should note that this information is furnished and not deemed 'filed' for purposes of Section 18 of the Exchange Act, meaning it doesn't carry the same legal liabilities. The key takeaway for investors from this filing is the need to review the accompanying press release for detailed financial performance, revenue figures, profitability, and any forward-looking guidance provided by the company.
02—Key points
Key Highlights
- Moderna announced its Q3 2023 financial results on November 2, 2023, via an 8-K filing.
- The primary content of the 8-K is a furnished press release detailing the company's financial performance.
- Investors must refer to the press release (Exhibit 99.1) for specific Q3 financial data and operational updates.
- The filing indicates that the information is furnished and not 'filed' under Section 18 of the Securities Exchange Act.
- No specific financial figures or operational metrics are detailed within the 8-K text itself; these are contained within the referenced press release.
- The filing includes the Cover Page Interactive Data File in its exhibits.
03—Questions
Frequently Asked Questions
Where can I find the specific financial results for Moderna's third quarter?
The specific financial results for Moderna's third quarter ended September 30, 2023, are detailed in the press release issued by the company on November 2, 2023, which is furnished as Exhibit 99.1 to this 8-K filing.
What are the key financial metrics reported in this 8-K?
This 8-K filing itself does not contain the specific financial metrics. Investors need to consult the accompanying press release (Exhibit 99.1) for details on revenue, profitability, earnings per share, and any other relevant financial performance indicators for Q3 2023.
Is the information in this 8-K legally binding in the same way as a 'filed' document?
No, the information in this 8-K, including the press release, is furnished and not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934. This means it generally does not subject the company to the same liabilities under that specific section.
Does this filing provide any new guidance or outlook for the future?
The 8-K filing serves to announce the Q3 results. Any forward-looking statements, guidance, or outlook would be included within the press release (Exhibit 99.1) that is furnished with this report. Investors should review the press release for this information.
04—Continue